Liquid Biopsy Market to Exceed US $2,893.7 Million by 2026: Qiagen N.V., Trovagene, Inc., Janssen Global Services, LLC, MDxHealth SA
Widespread acceptance of liquid biopsy technique in North America and steady adoption in developing regions is expected to drive g lobal liquid biopsy market revenues. The global market is expected to reach US$ 407 Mn in 2016, up from US$ 351 Mn in 2015. North America will continue to remain the largest market for liquid biopsy, accounting for over 50% share of the global market.
View full press release